ARCHIVES

BioSeek Awarded NIH SBIR For Compound Validation.

This article is from The Cancer Letter archive.

Vol. 29 No. 27 | July 4, 2003

Download PDF Visit The Full Archive

Related Articles

DCE Technical Support Contracts Recompetition Approved in Concept

November 22, 1991

PRI Fires Gilden, Compten, Sues For $1 Million By May Be Out Of Recompetition; NCI Is “Neutral”

August 8, 1986

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

Breast Cancer Survivors Report More Severe Fatigue Than Healthy Women

September 28, 2007

NIH Emerges From Republican Revolution With Another Increase in Appropriations

October 4, 1996

FDA Approves Afinitor For Advanced Kidney Cancer

March 27, 2009